Assertio Holdings (ASRT) Accounts Payables (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Accounts Payables came in at $5.9 million in Q1 2026, down 33.53% year-on-year from $8.9 million in Q1 2025, and down 34.4% quarter-over-quarter from $9.0 million in Q4 2025.
Assertio Holdings (ASRT) Accounts Payables (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Accounts Payables across 8 years of filings, most recently posting $5.9 million for Q1 2026.
- Accounts Payables for Q1 2026 came in at $5.9 million, down 33.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.9 million (down 33.53% YoY), and the FY2025 annual result was $9.0 million, down 38.83% from the prior year.
- Accounts Payables came in at $5.9 million for Q1 2026 at Assertio Holdings, down from $9.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $19.0 million in Q3 2023 to a low of $5.9 million in Q1 2026.
- The 5-year median for Accounts Payables is $10.9 million (2025), against an average of $11.2 million.
- Across the five-year window, Accounts Payables jumped 153.52% in 2024 and sank 43.16% in 2025, its largest moves.
- Assertio Holdings' Accounts Payables stood at $6.0 million in 2022, then surged by 124.32% to $13.4 million in 2023, then climbed by 9.65% to $14.7 million in 2024, then slumped by 38.83% to $9.0 million in 2025, then sank by 34.4% to $5.9 million in 2026.
- The last three Accounts Payables figures came in at $5.9 million (Q1 2026), $9.0 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 5.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.91 Mn |
| Dec 31, 2025 | 9.01 Mn |
| Sep 30, 2025 | 14.66 Mn |
| Jun 30, 2025 | 10.85 Mn |
| Mar 31, 2025 | 8.90 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Sep 30, 2024 | 13.15 Mn |
| Jun 30, 2024 | 15.27 Mn |
| Mar 31, 2024 | 15.65 Mn |
| Dec 31, 2023 | 13.44 Mn |
| Sep 30, 2023 | 19.00 Mn |
| Jun 30, 2023 | 11.18 Mn |
| Mar 31, 2023 | 6.17 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 8.37 Mn |
| Jun 30, 2022 | 9.42 Mn |
| Mar 31, 2022 | 8.52 Mn |
| Dec 31, 2021 | 6.69 Mn |
| Sep 30, 2021 | 7.67 Mn |
| Jun 30, 2021 | 16.48 Mn |